On November 21, 2023, Matthew Hill submitted his resignation, effective December 1, 2023, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the ? Company?) in order to pursue other professional endeavors. Mr. Hill acknowledged that his resignation was not the result of any disagreement relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | +7.76% | +11.08% | -27.36% |
Mar. 28 | B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating | MT |
Mar. 27 | Empire Metals targets key milestones in Australia | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.36% | 132M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.60% | 22.25B | |
-14.77% | 21.68B | |
-8.61% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- PDS Biotechnology Corporation Announces Resignation of Matthew Hill as Principal Financial Officer and Principal Accounting Officer, Effective December 1, 2023